Evidence map›Paper›PMID 23963599›Full record

ReviewJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2013

Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.

Lawrence M Phillips, Rory Hachamovitch, Daniel S Berman, Ami E Iskandrian, James K Min, Michael H Picard, Raymond Y Kwong, Matthias G Friedrich, Marielle Scherrer-Crosbie, Sean W Hayes and 12 more

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01471522 (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01471522 nacompletednot on this map

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

TypeinterventionalSponsorNYU Langone HealthRan2012 to 2023Enrolled5,179ConditionsCardiovascular Diseases, Coronary Disease, Coronary Artery Disease, Heart DiseasesArmscardiac catheterization, coronary artery bypass graft surgery, percutaneous coronary intervention, Lifestyle, Medication
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. SPECT myocardial perfusion imaging-based ischemia-guided early coronary revascularization improves survival: More fuel to the fire.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  3. The eye cannot see what the mind does not know.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  4. Article
  5. Brazilian Cardiovascular Rehabilitation Guideline - 2020.Arquivos brasileiros de cardiologia · 2020
    Article
  6. Coronary Heart Disease: Have We Reached a Plateau in Primary Prevention?Journal of the American Heart Association · 2020
    Article
  7. Article
  8. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Review
  9. Observational
  10. Review
  11. Article
  12. Review
  13. Serial cardiac SPECT studies: Technical issues and clinical implications.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  14. Immortality time and serial myocardial perfusion imaging: Only those who do not die may repeat the exam.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  15. Review
  16. Evaluating left ventricular systolic dysfunction: Stress echocardiography.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 6 countries.

Lawrence M PhillipsNew York University School of Medicine, 530 First Avenue, SKI-9U, New York, NY, 10016, USA, Lawrence.Phillips@nyumc.org.
Rory Hachamovitch
Daniel S Berman
Ami E Iskandrian
James K Min
Michael H Picard
Raymond Y Kwong
Matthias G Friedrich
Marielle Scherrer-Crosbie
Sean W Hayes
Tali Sharir
Gilbert Gosselin
Marco Mazzanti
Roxy Senior
Rob Beanlands
Paola Smanio
Abhi Goyal
Mouaz Al-Mallah
Harmony Reynolds
Gregg W Stone
David J Maron
Leslee J Shaw
Cedars-Sinai Medical Center · USEmory University · USMassachusetts General Hospital · USMontreal Heart Institute · CANew York University · USAssuta Medical Center · ILBrigham and Women's Hospital · USCleveland Clinic · USColumbia University Irving Medical Center · USCornell University · USInstituto Dante Pazzanese de Cardiologia · BRNorthwick Park Hospital · GBOspedali Riuniti di Ancona · ITOttawa Heart InstituteUniversity of Alabama at Birmingham · USVanderbilt University · US

Funding

Prognostic Impact and Arrhythmic Potential of Peri-infarct Zone by Cardiac MRIR01HL091157 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KWONG, RAYMOND Y · 2008 to 2012
$2.3M
NHLBI NIH HHS R01 HL091157
6 · The paper itself

Abstract

There is a preponderance of evidence that, in the setting of an acute coronary syndrome, an invasive approach using coronary revascularization has a morbidity and mortality benefit. However, recent stable ischemic heart disease (SIHD) randomized clinical trials testing whether the addition of coronary revascularization to guideline-directed medical therapy (GDMT) reduces death or major cardiovascular events have been negative. Based on the evidence from these trials, the primary role of GDMT as a front line medical management approach has been clearly defined in the recent SIHD clinical practice guideline; the role of prompt revascularization is less precisely defined. Based on data from observational studies, it has been hypothesized that there is a level of ischemia above which a revascularization strategy might result in benefit regarding cardiovascular events. However, eligibility for recent negative trials in SIHD has mandated at most minimal standards for ischemia. An ongoing randomized trial evaluating the effectiveness of randomization of patients to coronary angiography and revascularization as compared to no coronary angiography and GDMT in patients with moderate-severe ischemia will formally test this hypothesis. The current review will highlight the available evidence including a review of the published and ongoing SIHD trials.

Indexed as

Myocardial Perfusion ImagingMyocardial RevascularizationFractional Flow Reserve, MyocardialHumansMyocardial IschemiaPractice Guidelines as TopicRandomized Controlled Trials as TopicTreatment Outcome

Identifiers

PMID23963599
PMCPMC3954506
OpenAlexW2073900146

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.